BNET Industries

Indevus Pharmaceuticals Inc.

(IDEV) is in the Pharma Industry

Last Fiscal Year Sales:$77.7M
  • Public
  • US
Dow Jones Description

We identify and acquire products and product candidates that have differentiating features for multiple therapeutic areas. The Company has a primary commitment to urology and endocrinology. We are focused on individual compounds, rather than on earlier stage, relatively unproven drug discovery technologies. We continually seek product candidates for which we can define clear clinical trial pathways and sound commercialization strategies. Our pipeline is robust, fueled by our ability to identify and acquire promising new compounds and driven by our core competencies in clinical development and regulatory review activities. With the launch of SANCTURA in 2004, we established a specialty sales and marketing infrastructure. We believe our proven capability positions us strongly as a partner of choice for companies and research institutions seeking a collaborator to accomplish the development and commercialization of a broad array of pharmaceutical products in a timely and efficient manner.

Number of Employees 246
Contact Information

33 Hayden Ave

Lexington, Massachusetts 02421-7972

www.indevus.com

(781) 861-8444

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Endo Pharmaceuticals Announces Expiration of Cash Tender Offer for Ledgemont PhaRMASM...

    9/25/09 - Licensing / Contract - View Story

  • Repligen names former Indevus CEO Cooper to board

    8/25/09 - Board Member - Entering - View Story

News & Analysis

indevus pharmaceuticals inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Glenn L. Cooper President
James C. Gale Chief Investment Officer, Corporate Opportunities & Life Sciences
Brian Anderson Senior Vice President of Corporate Development
Kevin Pelin Senior Vice President Operations & General Manager
Lindsay A. Rosenwald Co-Founder
Robin L Decarlo

Board of Directors

Name (plus bio) Position
James F Pomroy Chairman, Internutria
Stephen C. McCluski Chairman
Harry Gray Board of Directors

Organization Position Status
Endo Pharmaceuticals Solutions Inc. President Current
Endo Pharmaceuticals Solutions Inc. Chairman & CEO Former
Eli Lilly and Company Former
Tufts University School of Medicine M.D. Former
Harvard College A.B. Former

Organization Position Status
Endo Pharmaceuticals Solutions Inc. Chief Investment Officer, Corporate Opportunities & Life Sciences Current
Signet Healthcare Partners Managing Director Current
Sanders Morris Harris managing director Current
CyDex Pharmaceuticals, Inc. Chairman Current
Cydex, Inc. Chairman of The Nominating and Corporate Governance Committee Current
Alpex Pharma Sa Chairman of the Board Current
Molecular Medicine Bioservices, Inc Board of Directors Current
Relm Wireless Corp. Board of Directors Current
Signet Healthcare Partners Board of Directors Current
Cedarburg Pharmaceuticals Inc Board of Directors Current
Latshaw Enterprises, Inc. Board of Directors Current
Amarin Corporation Plc Board of Directors Current
Signet Healthcare Partners Founder Former
Signet Healthcare Partners Partner Former
Gruntal & Co. Head of Principal Investment Activities Former
The Home Insurance Company Former
Indevus Pharmaceuticals, Inc. - NJ Chair of Board Former
CyDex Pharmaceuticals, Inc. Board of Directors Former
Functional Genetics, Inc. Board of Directors Former
Endo Pharmaceuticals Solutions Inc. Board of Directors Former
University of Chicago M.B.A. Former

From 2002 until early 2004, Mr. Anderson was an advisor and consultant to MontRidge, LLC, an investor relations firm specializing in biotechnology. He was President and Chief Executive Officer of Cognetix, Inc., a privately held biotechnology company in Salt Lake City, UT, from 1998 to 2002. Earlier, he was Senior Vice President of Marketing and Commercial Development at Interneuron (now Indevus) Pharmaceuticals and from 1987 until 1995 he held various executive positions in marketing, strategic planning and business development at Bristol-Myers Squibb. Mr. Anderson began his career in the pharmaceutical industry with the Upjohn Company of Canada, where he progressed through a series of sales, sales management and marketing management assignments. He currently sits on the Boards of two biotechnology companies, Oragenics, Inc. and Omni Genetics, Inc.

Organization Position Status
MediciNova, Inc. Executive Vice President, Corp Development Current
Endo Pharmaceuticals Solutions Inc. Senior Vice President of Corporate Development Current
Polymedix, Inc. Board of Directors Current
Cognetix, Inc. President & Chief Executive Officer Former
MediciNova, Inc. Chief Business Officer Former
Bristol-Myers Squibb Company Senior Manager Former
Oragenics, Inc. Board of Directors Former

Organization Position Status
Endo Pharmaceuticals Solutions Inc. Senior Vice President Operations & General Manager Current

Organization Position Status
Paramount Biosciences, LLC Chairman and Chief Executive Officer Current
Endo Pharmaceuticals Solutions Inc. Co-Founder Current
Chem Rx Chairman of the Board Current
Keryx Biopharmaceuticals, Inc. Board of Directors Current
Cougar Biotechnology, Inc. Board of Directors Current
Cougar,Inc. Director Current
Paramount Biosciences, LLC Managing Member Current
Cardiome Pharma Corp. Former
Neose Technologies, Inc. Former
Repligen Corporation Former
Avigen, Inc. Former
Cypress Bioscience, Inc. Former
Therapeutics Incorporated Former
Temple University School of Medicine M.D. Former
The Pennsylvania State University B.S. In Finance Former

Organization Position Status
Endo Pharmaceuticals Solutions Inc. Current

Organization Position Status
Endo Pharmaceuticals Solutions Inc. Chairman, Internutria Current

Organization Position Status
DeltaPoint Capital Management, LLC Operating Director Current
Endo Pharmaceuticals Solutions Inc. Chairman Current
DeltaPoint Capital Management, LLC Board of Directors Current
Bausch & Lomb Incorporated CFO & Senior Vice President Former
ImmunoGen, Inc. Chairman Former
ImmunoGen, Inc. Director Current
Ithaca College Bachelor of Science degree in Accounting Former

Organization Position Status
Endo Pharmaceuticals Solutions Inc. Board of Directors Current
advertisement
IndustryTop Rated
advertisement